SureSeq Myeloid Panels
Myeloid panels sized to your requirements
- 3-, 49- or 70-gene myeloid NGS panels
- Expert-led, evidence-based and customisable content
- Low-frequency SNVs and indels down to 1-2.5% VAF
- Rapid, streamlined workflow with Universal NGS Complete Workflow Solution
- Complimentary data analysis software with Interpret NGS Analysis Software
Myeloid malignancies are a heterogeneous group of diseases that are associated with a wide range of variants, ranging from single point mutations to structural variations. SureSeq™ Myeloid NGS solutions combine the rapid Universal NGS Workflow Solution hybridisation-based target enrichment with Interpret analysis software in the panel of your choice for accurate detection of key genes implicated in the characterisation of myeloid disorders.
The SureSeq™ Core MPN (+ BCR-ABL) panel
- Core content: CALR, JAK2, MPL SNVs and indels down to 1% VAF; customise by adding BCR-ABL translocation
- 1-day sample-to-sequencer: streamlined library preparation and rapid 30-minute hybridisation
The SureSeq™ Myeloid Plus Workflow
- Mid-size content: detect SNVs and indels in 49 genes implicated in myeloid malignancies down to 2.5% VAF (including robust detection of FLT3-ITDs and KMT2A-PTDs), together with 44 SNPs as ID markers and 4 sex chromosome genes
The SureSeq™ Pan-Myeloid panel
- Comprehensive content: confidently detect low-frequency SNVs and indels down to 1% VAF in 70 genes implicated in myeloid malignancies, including robust detection of FLT3-ITDs and KMT2A-PTDs
The SureSeq™ Core MPN (+ BCR-ABL) panel
Table 1: The SureSeq™ Core MPN Panel targets 4 exons in 3 genes implicated in myeloproliferative neoplasms (MPNs), covering various key MPN driver mutations.
Figure 1. Detection of a 52 bp deletion (type 1) in exon 9 of CALR (bottom panel), compared to a wild-type sample (top panel).
Figure 2. BCR-ABL translocation reported in Interpret.
The SureSeq™ Myeloid Plus Workflow
Table 2: The SureSeq™ Myeloid Plus Workflow targets 49 key genes implicated in myeloid disorders.
Figure 3. FLT3-ITDs of various sizes and regions containing multiple ITDs can be detected confidently.
The SureSeq™ Pan-Myeloid panel
Table 3: The SureSeq™ Pan-Myeloid Panel targets 70 genes implicated in a variety of myeloid disorders.
Figure 4. Illustration of the excellent coverage uniformity of the CEBPA gene.
Disclaimer
SureSeq™: For Research Use Only, not for use in diagnostic procedures. Product availability may vary from country to country. Contact your local representatives for availability.
Manufacturer and Trademarks: SureSeq™ (Oxford Gene Technology IP Limited)
Feature | Core MPN | Myeloid Plus | Pan-Myeloid |
Sample capacity | 24 or 96 samples per kit | 24 or 96 samples per kit | 24 or 96 samples per kit |
Number of targets | 3 genes | 49 (+4) gender marker genes | 70 myeloid genes and 4 gender marker genes |
Panel size | 1 kb | 132 kb | 221 kb |
DNA input recommended | >500 ng high-quality DNA | >500 ng high-quality DNA | >500 ng high-quality DNA |
Aberration Types | SNV, indel | SNV, indel, ITD, PTD | SNV, indel, ITD, PTD |
Limit of detection | SNVs / indels: 1% VAF Translocation (optional) | SNVs/ indels: 2.5 - 5% VAF | SNVs/indels: 1% VAF |
Gene list | CALR Exon 9, JAK2 Exons 12 and 14, MPL Exon 10 | AMELX, AMELY, ASXL1, BCOR, BCORL1, BRAF, CALR, CBL, CEBPA, CSF3R, CTNNA1, CUX1, DDX41, DNMT3A, ETNK1, ETV6, EZH2, FBXW7, FLT3, GATA2, GNAS, IDH1, IDH2, IKZF1, IRF1, JAK1, JAK2, KIT, KMT2A, KRAS, MPL, MYD88, NOTCH1, NPM1, NRAS, PAX5, PHF6, PPM1D, PTPN11, RAD21, RUNX1, SETBP1, SF3B1, SH2B3, SRSF2, STAG2, TET2, TGIF2LX, TGIF2LY, TP53, U2AF1, WT1 and ZRSR2 | ABL1, ASXL1, BCOR, BCORL1, BIRC3, BRAF, BTK, CALR, CBL, CDKN2A, CEBPA, CHEK2, CREBBP, CSF3R, CTNNA1, CUX1, CXCR4, DDX41, DNMT3A, EP300, ETNK1, ETV6, EZH2, FBXW7, FLT3, GATA1, GATA2, GNAS, GNB1, HRAS, IDH1, IDH2, IKZF1, IRF1, JAK1, JAK2, JAK3, KIT, KMT2A, KMT2C, KRAS, MPL, MYD88, NF1, NFE2, NOTCH1, NPM1, NRAS, PAX5, PDGFRA, PHF6, PLCG2, PPM1D, PTEN, PTPN11, RAD21, RUNX1, SETBP1, SF3B1, SH2B3, SRSF2 STAG2, STAT3 and STAT5B |
Ordering information
770001-24 | SureSeq™ Core MPN Panel |
770001-96 | SureSeq™ Core MPN Panel |
770024-24 | SureSeq™ Core MPN + BCR-ABL Panel |
770024-96 | SureSeq™ Core MPN + BCR-ABL Panel |
770002-24 | SureSeq™ Myeloid Plus Panel |
770002-96 | SureSeq™ Myeloid Plus Panel |
770003-24 | SureSeq™ Pan‐Myeloid Panel |
770003-96 | SureSeq™ Pan‐Myeloid Panel |
770510-24 | Universal NGS Workflow Solution V2 (24) |
770510-96 | Universal NGS Workflow Solution V2 (96) |
Sysmex Europe SE
Deelböge 19 D
22297 Hamburg
Germany
+49 (40) 527 26 0
+49 (40) 527 26 100
Product documents
Regulatory documents
Regulatory documents, such as Instructions for Use, can be accessed with a valid My Sysmex login:
Go to My Sysmex